Apollon Wealth Management’s Biogen BIIB Stock Holding History

Apollon Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$477K	Buy	2,210 +768	+53%	+$147K	0.01%	1037
2026 Q1	$264K	Buy	1,442 +21	+1%	+$3.87K	﹤0.01%	1174
2025 Q4	$250K	Buy	+1,421	New	+$232K	﹤0.01%	1138
2024 Q4	–	Sell	-1,642	Closed	-$318K	–	1201
2024 Q3	$318K	Sell	1,642 -636	-28%	-$133K	0.01%	892
2024 Q2	$528K	Sell	2,278 -818	-26%	-$178K	0.02%	661
2024 Q1	$668K	Sell	3,096 -1,898	-38%	-$445K	0.02%	592
2023 Q4	$1.29M	Buy	4,994 +3,990	+397%	+$980K	0.04%	370
2023 Q3	$258K	Buy	1,004 +300	+43%	+$80.2K	0.01%	751
2023 Q2	$201K	Buy	+704	New	+$210K	0.01%	872
2020 Q3	–	Sell	-44	Closed	-$12K	–	208
2020 Q2	$12K	Buy	+44	New	+$13.2K	0.01%	465

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

NGM

North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Apollon Wealth Management's BIIB Position: Q2 2026 in Review

Apollon Wealth Management increased its Biogen (BIIB) stake by 53% in Q2 2026, buying an estimated $147K and bringing the position to 2,210 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #1037.

Apollon Wealth Management first reported a position in BIIB in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.29M in Q4 2023. 221 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Apollon Wealth Management held 2,210 shares of Biogen worth $477K as of Q2 2026.
Apollon Wealth Management bought 768 Biogen shares in Q2 2026, an estimated $147K.
Biogen made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1037 holding.
Apollon Wealth Management first reported a position in Biogen in Q2 2020 and has held it in 10 quarters since.
Apollon Wealth Management's Biogen position peaked at $1.29M in Q4 2023.
221 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.